ERS International Congress, Paris 2018

Browse by day:
Saturday, 15.09.2018
Sunday, 16.09.2018
Monday, 17.09.2018
Tuesday, 18.09.2018
Wednesday, 19.09.2018


View the presentations you missed during Congress!

More than 1,700 webcasts and slide presentations, 1,600 e-posters and 4,200 abstracts from the International Congress in Paris and are now available. 

Citations should be made in the following way: Authors. Title. Eur Respir J 2018; 52: Suppl. 62, abstract number.

Mitochondrial dysfunction as a driver of lung disease

Chairs: R. Chambers (London, United Kingdom), C. Dela Cruz (New Haven, United States of America)
Aims: to describe the pathogenic roles of mitochondrial dysfunction in chronic respiratory diseases. Mitochondrial dysfunction is emerging as a driver of lung diseases. Recent studies on the mitochondrial dysfunction in diseases such as cancer and ageing have profoundly increased our understanding of how mitochondrial function regulates multiple cell functions, including energy production, apoptosis, calcium and reactive oxygen species signalling, and the generation of biosynthesis intermediates. Maintaining mitochondrial function is thus critical for ensuring proper organ function. An improved understanding of the mitochondrial dysfunction in lung diseases may promote the identification of novel therapeutic options for chronic respiratory diseases. It may also lead the way to considering repurposing already approved drugs such as metformin.
An introduction to mitochondria in lung biology and disease
S. Meiners (München, Germany)
Slide presentationWebcast
Slide presentationWebcast
Metabolic control of longevity
N. Sommer (Gießen, Germany)
Slide presentationWebcast
Slide presentationWebcast
Lung fibrosis - a disease of mitochondrial dysfunction
A. Mora (Pittsburgh, United States of America)
WebcastSlide presentation
WebcastSlide presentation
Role of mitochondria in the activation of immune cells in the lung
A. Tzouvelekis (Athens, Greece)
WebcastSlide presentation
WebcastSlide presentation